{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:04:03Z","timestamp":1790431443165,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.arcped.2015.11.002","type":"journal-article","created":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T23:16:02Z","timestamp":1450394162000},"page":"204-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Tol\u00e9rance de l\u2019ivermectine orale chez l\u2019enfant"],"prefix":"10.1016","volume":"23","author":[{"given":"A.","family":"Chosidow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gendrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2015.11.002_bib0250","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","article-title":"Multidrug resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites","volume":"86","author":"Cordon-Cardo","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.arcped.2015.11.002_bib0255","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-2275(20)31588-1","article-title":"The human ATP binding cassette (ABC) transporter superfamily","volume":"42","author":"Dean","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.arcped.2015.11.002_bib0260","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(82)91026-1","article-title":"Efficacy and tolerance of ivermectin in human onchocerciasis","volume":"2","author":"Aziz","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2015.11.002_bib0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1056\/NEJM198507183130301","article-title":"Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis","volume":"313","author":"Greene","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2015.11.002_bib0270","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.actatropica.2013.02.016","article-title":"The disappearance of onchocerciasis from the Itwara focus, western Uganda after elimination of the vector Simulium neavei and 19\u00a0years of annual ivermectin treatments","volume":"126","author":"Lakwo","year":"2013","journal-title":"Acta Trop"},{"key":"10.1016\/j.arcped.2015.11.002_bib0275","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(97)07081-5","article-title":"Randomised community-based trial of annual single dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes","volume":"351","author":"Bockarie","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2015.11.002_bib0280","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0035-9203(97)90040-7","article-title":"Reduced Loa loa microfilaria count ten to twelve months after a single dose of ivermectin","volume":"91","author":"Duong","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.arcped.2015.11.002_bib0285","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4269\/ajtmh.1996.55.477","article-title":"A comparative trial of a single dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children","volume":"55","author":"Marti","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.arcped.2015.11.002_bib0290","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.actatropica.2008.03.007","article-title":"A randomized, double-blind, multicenter clinical trial on the efficacy of ivermectin against intestinal nematode infections in China","volume":"106","author":"Wen","year":"2008","journal-title":"Acta Trop"},{"key":"10.1016\/j.arcped.2015.11.002_bib0295","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/infdis\/169.5.1076","article-title":"A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis","volume":"169","author":"Gann","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arcped.2015.11.002_bib0300","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1086\/313787","article-title":"Treatment of cutaneous larva migrans","volume":"30","author":"Caumes","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arcped.2015.11.002_bib0305","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0151-9638(04)93668-X","article-title":"Ivermectine","volume":"131","author":"Develoux","year":"2004","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.arcped.2015.11.002_bib0310","doi-asserted-by":"crossref","first-page":"40232","DOI":"10.1074\/jbc.R112.406280","article-title":"Glutamate-gated chloride channels","volume":"287","author":"Wolstenholme","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcped.2015.11.002_bib0315","doi-asserted-by":"crossref","first-page":"e95072","DOI":"10.1371\/journal.pone.0095072","article-title":"Caenorhabditis elegans neuromuscular junction: GABA receptors and ivermectin action","volume":"9","author":"Hernando","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.arcped.2015.11.002_bib0320","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/expr.1993.1064","article-title":"Haemonchus contortus: ivermectin-induced paralysis of the pharynx","volume":"77","author":"Geary","year":"1993","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.arcped.2015.11.002_bib0325","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0026-895X(25)13064-2","article-title":"Effect of avermectin B1a on chick neuronal gamma-aminobutyrate receptor channels expressed in Xenopus oocytes","volume":"32","author":"Sigel","year":"1987","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.arcped.2015.11.002_bib0330","unstructured":"HCSP. URL\u00a0http:\/\/www.sante.gouv.fr\/IMG\/pdf\/Recommandations_HCSP_gale_conduite_a_tenir_nov_2012_.pdf n.d. Consult\u00e9 le 9 novembre 2012."},{"key":"10.1016\/j.arcped.2015.11.002_bib0335","first-page":"34","article-title":"Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin","volume":"83","author":"Lawrence","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.arcped.2015.11.002_bib0340","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S1473-3099(15)00132-2","article-title":"Prevalence of scabies and impetigo worldwide: a systematic review","volume":"15","author":"Romani","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.arcped.2015.11.002_bib0345","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1371\/journal.pntd.0000467","article-title":"High burden of impetigo and scabies in a tropical country","volume":"3","author":"Steer","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.arcped.2015.11.002_bib0350","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa0905471","article-title":"Oral ivermectin versus malathion lotion for difficult-to-treat head lice","volume":"362","author":"Chosidow","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2015.11.002_bib0355","doi-asserted-by":"crossref","first-page":"e1355","DOI":"10.1542\/peds.2015-0746","article-title":"Head lice","volume":"135","author":"Devore","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcped.2015.11.002_bib0360","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s002800051053","article-title":"Multidrug resistance: molecular mechanisms and clinical relevance","volume":"40\u00a0Suppl","author":"Ling","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.arcped.2015.11.002_bib0365","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2174\/138920112800399301","article-title":"Treatment of MDR1\u00a0mutant dogs with macrocyclic lactones","volume":"13","author":"Geyer","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.arcped.2015.11.002_bib0370","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.neuro.2011.12.009","article-title":"Barriers in the developing brain and neurotoxicology","volume":"33","author":"Ek","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.arcped.2015.11.002_bib0375","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","article-title":"Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs","volume":"77","author":"Schinkel","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.arcped.2015.11.002_bib0380","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00008571-200111000-00012","article-title":"Ivermectin sensitivity in collies is associated with a deletion mutation of the MDR1\u00a0gene","volume":"11","author":"Mealey","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.arcped.2015.11.002_bib0385","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0065-308X(05)60004-8","article-title":"Wolbachia bacterial endosymbionts of filarial nematodes","volume":"60","author":"Taylor","year":"2005","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.arcped.2015.11.002_bib0390","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/339344","article-title":"Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions","volume":"185","author":"Keiser","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arcped.2015.11.002_bib0395","first-page":"707","article-title":"Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials","volume":"67","author":"De Sole","year":"1989","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.arcped.2015.11.002_bib0400","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","article-title":"Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection","volume":"350","author":"Gardon","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2015.11.002_bib0405","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/009127002401382731","article-title":"Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects","volume":"42","author":"Guzzo","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.arcped.2015.11.002_bib0410","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMcp052784","article-title":"Clinical practices. Scabies","volume":"354","author":"Chosidow","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2015.11.002_bib0415","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMct0910329","article-title":"Permethrin and ivermectin for scabies","volume":"362","author":"Currie","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2015.11.002_bib0420","doi-asserted-by":"crossref","first-page":"e998","DOI":"10.1371\/journal.pntd.0000998","article-title":"Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus","volume":"5","author":"Osei-Atweneboana","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.arcped.2015.11.002_bib0425","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1086\/421776","article-title":"First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei","volume":"39","author":"Currie","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arcped.2015.11.002_bib0430","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/archdermatol.2009.125","article-title":"Longitudinal evidence of increasing in vitro tolerance of scabies mites to ivermectin in scabies-endemic communities","volume":"145","author":"Mounsey","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.arcped.2015.11.002_bib0435","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1056\/NEJMe1211124","article-title":"Topical ivermectin\u00a0\u2013\u00a0a step toward making head lice dead lice?","volume":"367","author":"Chosidow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2015.11.002_bib0440","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1056\/NEJMoa1200107","article-title":"Topical 0.5\u00a0% ivermectin lotion for treatment of head lice","volume":"367","author":"Pariser","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2015.11.002_bib0445","unstructured":"CRAT. URL: http:\/\/www.lecrat.org\/articleSearch.php3?id_groupe=12 n.d. Consult\u00e9 le 16\u00a0septembre 2014."},{"key":"10.1016\/j.arcped.2015.11.002_bib0450","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1006\/bbrc.1997.6855","article-title":"Function of P-glycoprotein expressed in placenta and mole","volume":"235","author":"Nakamura","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.arcped.2015.11.002_bib0455","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.placenta.2004.05.013","article-title":"P-glycoprotein expression of the human placenta during pregnancy","volume":"26","author":"Gil","year":"2005","journal-title":"Placenta"},{"key":"10.1016\/j.arcped.2015.11.002_bib0460","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0035-9203(93)90146-H","article-title":"Absence of any adverse effect of inadvertent ivermectin treatment during pregnancy","volume":"87","author":"Chippaux","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.arcped.2015.11.002_bib0465","first-page":"443","article-title":"Control of onchocerciasis with ivermectin: results of a mass campaign in northern Cameroon","volume":"69","author":"Prod\u2019hon","year":"1991","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.arcped.2015.11.002_bib0470","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1360-2276.2003.01142.x","article-title":"Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis","volume":"8","author":"Gyapong","year":"2003","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.arcped.2015.11.002_bib0475","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF00265962","article-title":"Ivermectin levels in human breastmilk","volume":"45","author":"Ogbuokiri","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.arcped.2015.11.002_bib0480","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/bjd.12454","article-title":"Treatment of scabies with oral ivermectin in 15\u00a0infants: a retrospective study on tolerance and efficacy","volume":"169","author":"B\u00e9court","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.arcped.2015.11.002_bib0485","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.arcped.2013.09.008","article-title":"Traitement de la gale\u00a0: des recommandations g\u00e9n\u00e9rales aux applications p\u00e9diatriques","volume":"20","author":"Gendrel","year":"2013","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2015.11.002_bib0245","unstructured":"Novel Treatment Soolantra\u00ae (ivermectin) Cream, 1\u00a0%, Now Approved \u01c0 Rosacea.org n.d. URL: http:\/\/www.rosacea.org\/weblog\/novel-treatment-soolantra%C2\u00a0%AE-ivermectin-cream-1-now-approved (accessed September 15, 2015)."}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X15004236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X15004236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T21:02:31Z","timestamp":1748725351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X15004236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0929693X15004236"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2015.11.002","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tol\u00e9rance de l\u2019ivermectine orale chez l\u2019enfant","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2015.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}